TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression. [electronic resource]
Producer: 20040930Description: 159-70 p. digitalISSN:- 0014-4827
- Animals
- CDC2 Protein Kinase -- metabolism
- Carbazoles -- pharmacology
- Caspase 3
- Caspases -- metabolism
- Cell Cycle -- drug effects
- Cell Death -- drug effects
- Cyclin A -- metabolism
- Cyclin B -- metabolism
- Cyclin B1
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclins -- metabolism
- G2 Phase -- drug effects
- Genes, Tumor Suppressor
- Humans
- Immediate-Early Proteins -- genetics
- Indoles -- pharmacology
- Maleimides -- pharmacology
- Mice
- NIH 3T3 Cells
- Nocodazole -- pharmacology
- Protein Binding -- drug effects
- Protein Kinase C -- metabolism
- Protein Kinase C-delta
- Pyridines -- pharmacology
- RNA, Messenger -- drug effects
- Retinoblastoma Protein -- metabolism
- Signal Transduction -- drug effects
- Tumor Suppressor Protein p53 -- metabolism
- Tumor Suppressor Proteins
- U937 Cells
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.